Skip to content
1 min left
0% read
LyRise logo

LyRise

Technology Company
United States
Founded 2021
40

The platform for companies to build AI easier & faster

Share:

The Platform for Companies to Build AI Easier & Faster

LyRise enables companies through a simple chat interface to find out what their highest ROI AI use case is, matches them with AI agents and/or AI experts to develop these use cases in ⅓ the time and cost it usually takes.

Our vision is to augment intelligence for businesses.

Our mission is to unlock AI for 1M companies.

We've worked with companies such as OLX, Affectiva, Jumia, and our expert network has worked previously at Google, Microsoft, Tesla, Meta, and others.

Visit our website or contact us on [email] for more information.

Frequently Asked Questions About LyRise

LyRise is a finance company. The platform for companies to build AI easier & faster

The platform for companies to build AI easier & faster. LyRise enables companies through a simple chat interface to find out what their highest ROI AI use case is, matches them with AI agents and/or AI experts to develop these use cases in ⅓ the time and cost it usually takes.

Our vision is to aug.

LyRise has been operating since 2021. You can verify their legitimacy through their official website and social media presence.

LyRise operates in the finance sector of the cryptocurrency industry. Compare LyRise with other finance companies on Crypto News Navigator to evaluate services, features, and reputation before making your decision.

Before using LyRise, research their track record (operating since 2021), verify their regulatory compliance, read user reviews, and understand their fee structure. Never share your private keys with any service, and start with small amounts until you are comfortable with the platform.

Safety depends on multiple factors including regulatory compliance, security practices, and track record. LyRise is based in United States, has been operating since 2021. Always enable two-factor authentication, use strong passwords, and never store large amounts on any third-party platform.

LyRise is based in United States, North America.

LyRise was founded in 2021. The company currently has 40 employees.

LyRise Details

LyRise Tags

More About LyRise

Work Model Details
Employees engage in a combination of remote and on-site work.

Latest from Academy

Blast Ecosystem Grew 400% in Six Months and Nobody Talked About It

Blast Ecosystem Grew 400% in Six Months and Nobody Talked About It

The Blast ecosystem has been crypto's most misunderstood narrative of 2026. While the market fixated on a 98.3% drawdown from all-time highs, less-publicized on-chain data tells a counterintuitive story. Three major protocol upgrades shipped since January 2025, 10% TVL growth appeared week-on-week in April, and 279,520 holders remain HODLing their positions on a chain the world has given up on.

7m
 Why Tokenlon's Revenue Doesn't Match Its Token Price

Why Tokenlon's Revenue Doesn't Match Its Token Price

DEX aggregation is "solved" in DeFi, right? 1inch, Jupiter, Paraswap have you covered. Except the data paints a different picture. Tokenlon quietly processes over $120 million in weekly trading volume and a 99.71% order success rate, yet remains shockingly absent from discussion in industry forums and panels. Either the market is correct and Tokenlon's fundamentals are not what we perceive, or a highly-traveled protocol has been willfully ignored.

Mia Halland logoMia HallandApr 26, 2026
8m
Sixty-Five Million in BioDAOs, BIO at One Cent

Sixty-Five Million in BioDAOs, BIO at One Cent

Bio Protocol's CEO recently revealed that PeptAI designed a new ADHD peptide candidate in 24 hours for roughly $1,500 in initial lab validation. While crypto traders focus on memecoins, Bio Protocol has quietly built a scientific funding platform backed by Pfizer Ventures, Binance Labs, and Arthur Hayes' Maelstrom Fund. The bio price trades at $0.031, down 96.5% from its all-time high of $0.889, despite $65M in combined BioDAO research funding and active clinical trials.

8m